Ebitda تغيير تاريخ
AstraZeneca USD 5.16B 510M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
Essilor EUR 4.34B 1.25B 2026-06
Fresenius EUR 988M 37M 2026-06
Fresenius Medical Care EUR 843.66M 19.66M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.6B 69M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Philips EUR 910M 343M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12